BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24139892)

  • 1. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit.
    Finger PT; Tena LB; Semenova E; Aridgides P; Choi WH
    Brachytherapy; 2014; 13(3):275-80. PubMed ID: 24139892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.
    Hykin PG; McCartney AC; Plowman PN; Hungerford JL
    Br J Ophthalmol; 1990 Jan; 74(1):36-9. PubMed ID: 2106340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
    Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
    Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive orbital extension of posterior uveal melanomas.
    Shields JA; Shields CL
    Ophthalmic Plast Reconstr Surg; 1991; 7(4):238-51. PubMed ID: 1764421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
    Masoomian B; Mashayekhi A; Shields JA; Shields CL
    Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of primary and secondary enucleation for uveal melanoma.
    Pham CM; Custer PL; Couch SM
    Orbit; 2017 Dec; 36(6):422-427. PubMed ID: 28812919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma.
    Zehetmayer M; Kitz K; Menapace R; Ertl A; Heinzl H; Ruhswurm I; Georgopoulos M; Dieckmann K; Pötter R
    Radiother Oncol; 2000 May; 55(2):135-44. PubMed ID: 10799725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
    Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
    Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orbital Exenteration in Patient with Metastatic Choroidal Melanoma - a Case Report].
    Justusová P; Štubňa M; Veselovský M; Lipková B
    Cesk Slov Oftalmol; 2016; 72(3):92-96. PubMed ID: 27658977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evisceration and ocular tumors: What are the consequences?
    Lemaître S; Lecler A; Lévy-Gabriel C; Reyes C; Desjardins L; Gentien D; Zmuda M; Jacomet PV; Lumbroso-Le Rouic L; Dendale R; Vincent-Salomon A; Pierron G; Galatoire O; Cassoux N
    J Fr Ophtalmol; 2017 Feb; 40(2):93-101. PubMed ID: 28126270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
    Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.
    Fili M; Lundell G; Lundell M; Seregard S
    Br J Ophthalmol; 2014 Oct; 98(10):1349-54. PubMed ID: 24825846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital recurrence of choroidal melanoma 20 years after enucleation.
    Shields JA; Augsburger JJ; Dougherty MJ
    Am J Ophthalmol; 1984 Jun; 97(6):767-70. PubMed ID: 6731541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E; Finger PT
    JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-day session LINAC-based stereotactic radiosurgery of posterior uveal melanoma.
    Furdova A; Strmen P; Waczulikova I; Chorvath M; Sramka M; Slezak P
    Eur J Ophthalmol; 2012; 22(2):226-35. PubMed ID: 21534252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrascleral extension of choroidal melanoma after iodine-125 brachytherapy treatment: a case series.
    Mustak H; Lo C; Cohen LM; Tran A; Almanzor R; McCannel TA; Goldberg RA; Rootman DB
    Eye (Lond); 2023 Feb; 37(2):249-255. PubMed ID: 34987200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.